Glycated Hemoglobin Testing Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET OVERVIEW
:
A glycosylated hemoglobin test measures the amount of glucose (sugar) in blood. The test is sometimes referred to as A1c or HbA1c. Detect elevated sugar levels among those with prediabetes, which can progress to diabetes, heart disease, and stroke. It's a simple blood test that's used to identify diabetes.
MARKET SCOPE
The "Glycated Hemoglobin Testing Market to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of glycated hemoglobin testing market with detailed market segmentation by of Product type, Application, End Users. The glycated hemoglobin testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in glycated hemoglobin testing market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
MARKET DYNAMICS
Drivers:
Restraints
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the glycated hemoglobin testing market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The glycated hemoglobin testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting glycated hemoglobin testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the glycated hemoglobin testing market in these regions.
IMPACT OF COVID-19 ON GLYCATED HEMOGLOBIN TESTING MARKET:
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the glycated hemoglobin testing market in 2021.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
By Test Type
By Technique
By End User
MARKET PLAYERS
The report covers key developments in the glycated hemoglobin testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from glycated hemoglobin testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for glycated hemoglobin testing market in the global market. Below mentioned is the list of few companies engaged in the glycated hemoglobin testing market.
The report also includes the profiles of key players in glycated hemoglobin testing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
:
A glycosylated hemoglobin test measures the amount of glucose (sugar) in blood. The test is sometimes referred to as A1c or HbA1c. Detect elevated sugar levels among those with prediabetes, which can progress to diabetes, heart disease, and stroke. It's a simple blood test that's used to identify diabetes.
MARKET SCOPE
The "Glycated Hemoglobin Testing Market to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of glycated hemoglobin testing market with detailed market segmentation by of Product type, Application, End Users. The glycated hemoglobin testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in glycated hemoglobin testing market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- n the basis of test type, the market is segmented into Point-of-Care HBA1C Testing products and Laboratory HBA1C Testing products
- n the basis of technique, the market is segmented into Chromatography, Immunoassay and Other Techniques.
- n the basis of end User, the market is segmented into Academic & Research Institutes, Diagnostic Centers, Hospitals and Other End Users.
MARKET DYNAMICS
Drivers:
- Increased R&D activities in early diagnosis and effective disease treatment, as well as a rise in diabetic patients, a growing geriatric population, technological breakthroughs in diabetes diagnosis, expansion in the home healthcare industry, and an increase in diabetic patients are all driving this market ahead.
In the near future, the market is predicted to grow due to an increase in the diabetes population and increased awareness of POC HbA1c testing in developing nations.
Restraints
The market's growth is hampered by the availability of substitutes and the high costs associated with glycated haemoglobin testing market.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the glycated hemoglobin testing market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The glycated hemoglobin testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting glycated hemoglobin testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the glycated hemoglobin testing market in these regions.
IMPACT OF COVID-19 ON GLYCATED HEMOGLOBIN TESTING MARKET:
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the glycated hemoglobin testing market in 2021.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Glycated Hemoglobin Testing Market Report Analysis
Glycated Hemoglobin Testing Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Abbott
- Beckman Coulter Inc
- Bio Rad Laboratories Inc
- DiaSys Diagnostic Systems GmbH
- F Hoffmann La Roche Ltd
- Randox Laboratories Ltd
- SEBIA
- TaiDoc Technology Corporation
- Tosoh Bioscience Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Test Type
- Point-of-Care HBA1C Testing products and Laboratory HBA1C Testing products
By Technique
- Chromatography
- Immunoassay and Other Techniques
By End User
- Academic & Research Institutes
- Diagnostic Centers
- Hospitals
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report covers key developments in the glycated hemoglobin testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from glycated hemoglobin testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for glycated hemoglobin testing market in the global market. Below mentioned is the list of few companies engaged in the glycated hemoglobin testing market.
The report also includes the profiles of key players in glycated hemoglobin testing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Abbott
- Beckman Coulter, Inc
- Bio-Rad Laboratories, Inc.
- DiaSys Diagnostic Systems GmbH
- F. Hoffmann-La Roche Ltd
- Randox Laboratories Ltd.
- SEBIA
- TaiDoc Technology Corporation
- Tosoh Bioscience, Inc.
- Trinity Biotech Plc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Glycated Hemoglobin Testing Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Test Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Abbott
2. Beckman Coulter, Inc
3. Bio-Rad Laboratories, Inc.
4. DiaSys Diagnostic Systems GmbH
5. F. Hoffmann-La Roche Ltd
6. Randox Laboratories Ltd.
7. SEBIA
8. TaiDoc Technology Corporation
9. Tosoh Bioscience, Inc.
10. Trinity Biotech Plc.
11. Alere Inc.
12. Beckman Coulter, Inc.
13. Bayer AG,
14. Randox Laboratories Ltd
15. ARKRAY, Inc.
1. Abbott
2. Beckman Coulter, Inc
3. Bio-Rad Laboratories, Inc.
4. DiaSys Diagnostic Systems GmbH
5. F. Hoffmann-La Roche Ltd
6. Randox Laboratories Ltd.
7. SEBIA
8. TaiDoc Technology Corporation
9. Tosoh Bioscience, Inc.
10. Trinity Biotech Plc.
11. Alere Inc.
12. Beckman Coulter, Inc.
13. Bayer AG,
14. Randox Laboratories Ltd
15. ARKRAY, Inc.
Get Free Sample For